Clinical Trial: A Prospective, Single-Arm, Multicenter, Exploratory Clinical Study of Iodine125 Seed Implantation Combined with AipaluoliTuoworuilidan (a Novel Bispecific Antibody) and AG Regimen for Locally Advanced Pancreatic Cancer (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Single-Arm, Multicenter, Exploratory Clinical Study of Iodine125 Seed Implantation Combined with AipaluoliTuoworuilidan (a Novel Bispecific Antibody) and AG Regimen for Locally Advanced Pancreatic Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133962

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340153

Published by HT Digital Content Services with permission from He...